IgniteData Advances Clinical Trial Efficiencies with Successful Deployment at Leading Cancer Center
NEW YORK, March 31, 2025 /PRNewswire/ -- IgniteData has announced a collaboration with Memorial Sloan Kettering Cancer Center (MSK) and...
EHR
Inozyme Pharma to Participate in the 24th Annual Needham Virtual Healthcare Conference
BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company...
Tempus Exhibits 4 Abstracts at the 2025 American College of Cardiology Annual Meeting
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient...
Legal Steroids For Muscle Growth 2025: Best Steroids For (Bodybuilding & Bulking) By CrazyBulk in USA
NEW YORK, March 29, 2025 (GLOBE NEWSWIRE) -- While there is a huge range of steroids available in the market,...
Castle Biosciences’ DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups
New, combined validation cohort of 1,412 patients with high-risk squamous cell carcinoma (SCC) demonstrates that the addition of DecisionDx-SCC to...
Intermedia Named a Leader in the Aragon Research Globe™ for the Intelligent Contact Center for SMB, 2025
Bringing enterprise-grade AI to SMBs, Intermedia is redefining what a modern contact center can do for businesses of all sizes—helping...
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
UNLOXCYT™ (cosibelimab-ipdl) approved by U.S. FDA as first and only anti-PD-L1 treatment for advanced cutaneous squamous cell carcinomaWALTHAM, Mass., March 28,...
Beyond Medical Technologies Provides Business Strategy and Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - March 28, 2025) - Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF)...
Winstrol Steroid: Benefits, Side Effects, Results & Buy Winstrol Pills Alternatives From CrazyBulk
NEW YORK, March 28, 2025 (GLOBE NEWSWIRE) -- There exist numerous approaches to enhance muscle growth, a tantalizing prospect for...
VitalHub Reports Fourth Quarter and Annual 2024 Results
Annual Recurring Revenue (ARR)⁽¹⁻²⁾ up 59% YoY to $71.1 millionTotal Revenue up 51% YoY to $20.6 millionAdjusted EBITDA ⁽²⁾ up...
INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update
Company to Host Conference Call Today, March 27, at 4:30pm ETBOCA RATON, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- INmune...
Kevala Announces Integration with PointClickCare via Marketplace to Optimize Workforce Management for Skilled Nursing Facilities
SEATTLE, March 27, 2025 /PRNewswire/ -- Kevala, a pioneer in workforce management solutions for post acute-care, is excited to announce...
10Bridge Announces Achievement of a Major Deployment Milestone within the Accountable Care Market
CARROLLTON, Ga., March 27, 2025 /PRNewswire/ -- 10Bridge, 121G Consulting's data interoperability subsidiary, is proud to announce a major milestone...
Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025
Dear Shareholders, TAMPA, FL, March 27, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX) (“Wellgistics Health”), This time last...
New Jersey Innovation Institute and Cognome Announce Strategic Partnership to Advance AI-Powered Healthcare Solutions
NEWARK, N.J., March 26, 2025 /PRNewswire/ -- The New Jersey Innovation Institute (NJII), and Cognome are pleased to announce a strategic...
Nayya Announces Referral Agreement with Mercer to Introduce Nayya to Employers across the United States
NEW YORK, March 26, 2025 /PRNewswire/ -- Nayya today announced that it is working with Mercer to introduce its cutting-edge...
Catheter Precision to Participate in and Share Data at Upcoming Industry Conferences
FORT MILL, S.C., March 26, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device...
Asgard Therapeutics appoints immunology expert Shane Olwill as Chief Development Officer
Pioneering cancer immunology company Asgard strengthens leadership team as it progresses its lead asset AT-108 towards clinical trials Shane brings...
ProsperityEHR Debuts Next-Gen EHR to Keep Behavioral Health Practices Thriving
Built by Epic alums, clinicians, and clinical operators, ProsperityEHR enhances treatment delivery, reduces administrative burdens, and empowers providers to focus...
Belay Diagnostics Partners with GenomOncology to Support High-Performance Liquid Biopsy Test for Central Nervous System Cancer Detection
CLEVELAND, March 25, 2025 /PRNewswire/ -- Belay Diagnostics announces its partnership with GenomOncology (GO), a precision medicine software company that provides...